Medicure (CVE:MPH) Shares Cross Above Fifty Day Moving Average – Time to Sell?

Medicure Inc. (CVE:MPH) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$1.14 and traded as high as C$1.20. Medicure shares last traded at C$1.20, with a volume of 2,000 shares changing hands.

Medicure Price Performance

The stock’s fifty day moving average price is C$1.14 and its two-hundred day moving average price is C$1.17. The firm has a market capitalization of C$11.48 million, a price-to-earnings ratio of -1.62 and a beta of 0.62. The company has a current ratio of 1.02, a quick ratio of 1.29 and a debt-to-equity ratio of 6.90.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.